Universitätsstraße 14-16
Münster, 48143
Germany
University of Münster
zapnometinib, MEK inhibitor, host targeting agent, COVID-19, drug development, broad-spectrum antiviral
SARS-CoV-2, Zapnometinib, host-targeted antiviral, direct-acting antiviral, drug resistance
Anagallis arvensis, Herpes simplex virus, membrane fusion, plaque reduction, saponins, anagallosides